Oxyethylidenediphosphonic acid
Oxyethylidenediphosphonic acid Brand names, Oxyethylidenediphosphonic acid Analogs
- Acetodiphosphonic acid
- Acide etidronique [INN-French]
- Acido etidronico [INN-Spanish]
- Acidum etidronicum [INN-Latin]
- Cintichem Technetium 99m Hedspa
- Dequest 2010
- Dequest 2015
- Dequest Z 010
- Didronel
- Didronel IV
- EHDP
- Etidronate Disodium
- Etidronic acid
- Etidronic acid [USAN:BAN:INN]
- Etidronsaeure
- Ferrofos 510
- HEDP
- Hydroxyethanediphosphonic acid
- MPI Stannous Diphosphonate
- Osteoscan
- Oxyethylidenediphosphonic acid
- Turpinal SL
Oxyethylidenediphosphonic acid Brand Names Mixture
- No information avaliable
Oxyethylidenediphosphonic acid Chemical_Formula
C24H25NO4
Oxyethylidenediphosphonic acid RX_link
http://www.rxlist.com/cgi/generic3/flavoxate.htm
Oxyethylidenediphosphonic acid fda sheet
Oxyethylidenediphosphonic acid msds (material safety sheet)
Oxyethylidenediphosphonic acid Synthesis Reference
No information avaliable
Oxyethylidenediphosphonic acid Molecular Weight
391.46 g/mol
Oxyethylidenediphosphonic acid Melting Point
No information avaliable
Oxyethylidenediphosphonic acid H2O Solubility
10 mg/L
Oxyethylidenediphosphonic acid State
Solid
Oxyethylidenediphosphonic acid LogP
4.636
Oxyethylidenediphosphonic acid Dosage Forms
Tablets (100 mg)
Oxyethylidenediphosphonic acid Indication
For symptomatic relief of dysuria, urgency, nocturia, suprapubic pain, frequency and incontinence as may occur in cystitis, prostatitis, urethritis, urethrocystitis/urethrotrigonitis.
Oxyethylidenediphosphonic acid Pharmacology
Flavoxate is a spasmolytic flavone derivative that acts by relaxing the smooth muscle in the urinary tract. Flavoxate is a competitive muscarinic receptor antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and urinary frequency. Muscarinic receptors play an important role in several major cholin-ergically mediated functions, including contractions of urinary bladder smooth muscle and stimulation of salivary secretion.
Oxyethylidenediphosphonic acid Absorption
Well absorbed from gastrointestinal tract.
Oxyethylidenediphosphonic acid side effects and Toxicity
The oral LD50 for flavoxate HCl in rats is 4273 mg/kg. The oral LD50 for flavoxate HCl in mice is 1837 mg/kg. Symptoms of overdose include convulsions, decreased ability to sweat, (warm, red skin, dry mouth, and increased body temperature), hallucinations, increased heart rate and blood pressure, and mental confusion.
Oxyethylidenediphosphonic acid Patient Information
Oxyethylidenediphosphonic acid Organisms Affected
Humans and other mammals
